These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7247498)

  • 21. [The presence and significance of HBe antigens and anti-HBe antibodies in HBs antigen positive patients].
    Zivanović-Marinković V; Kaljalović R; Marinković V; Dumović B; Lazarov A; Nanusević N; Krstić L; Parabucki S
    Zb Vojnomed Akad; 1981; 23():24-6. PubMed ID: 6963836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple hepatitis B virus markers in dialysis patients.
    Acchiardo S; Cockrell S
    Trans Am Soc Artif Intern Organs; 1982; 28():308-11. PubMed ID: 7164253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HBeAg/anti-HBe system and development of primary hepatocellular carcinoma in patients with HBsAg-positive liver cirrhosis.
    Musca A; Cordova C; Barnaba V; Bonavita MS; Levrero M; Zaccari C; Balsano F
    Hepatogastroenterology; 1983 Feb; 30(1):3-5. PubMed ID: 6299916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of HBeAg on vertical transmission of hepatitis B virus (author's transl)].
    Yu HL
    Zhonghua Yi Xue Za Zhi; 1981 Jul; 61(7):399-401. PubMed ID: 6805897
    [No Abstract]   [Full Text] [Related]  

  • 25. [HBeAg and anti-HBe levels in HBsAg positive blood donors].
    Hasçelik G; Günalp A
    Mikrobiyol Bul; 1989 Jan; 23(1):23-9. PubMed ID: 2626096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hepatitis B virus in a hemodialysis unit].
    Guma CL; Colombato LO; Alvarez E; Franco CO; Planes N
    Medicina (B Aires); 1985; 45(5):491-5. PubMed ID: 3842456
    [No Abstract]   [Full Text] [Related]  

  • 27. [The behavior of the HBeAg-anti-HBe system in chronic hepatitis].
    Musca A; Cordova C; Barnaba V; Bonavita MS; Zaccari C; Levrero M
    Minerva Dietol Gastroenterol; 1983; 29(1):19-26. PubMed ID: 6843853
    [No Abstract]   [Full Text] [Related]  

  • 28. [Detection of HBeAg among HBsAg-positive patients with various hepatic diseases and epidemiologic significance of the findings].
    Xu HW
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Aug; 4(4):226-9. PubMed ID: 6640636
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatitis B in hemodialysis patients: significance of HBeAg.
    Miller DJ; Williams AE; Le Bouvier GL; Dwyer JM; Grant J; Klatskin G
    Gastroenterology; 1978 Jun; 74(6):1208-13. PubMed ID: 306361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Incidence of e-antigen and antibodies against it in a selected group of HBsAg-positive Vietnamese citizens].
    Michal L; Pullmann R; Szilágyiová M; Konvit I; Straka S; Skraciková J
    Cas Lek Cesk; 1991 Jan; 130(3):82-3. PubMed ID: 2004393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunosuppressive therapy in patients with HBeAg-positive chronic active hepatitis B?].
    Maier KP; Lepiorz H; Berthold H; Gerok W
    Leber Magen Darm; 1982 Aug; 12(4):150-3. PubMed ID: 7132529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tests for Dane particles in serum concentrates of HBsAg positive hemodialysis patients.
    Hess G; Arnold W; Koesters W; Meyer zum Büschenfelde KH
    Clin Nephrol; 1979 Jan; 11(1):18-22. PubMed ID: 428150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
    Chen DS; Sung JL; Lai MY
    Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of HBsAg-,HBeAg-positive chronic active hepatitis with adenine arabinoside. A case report with clinical remission and seroconversion to anti-HBs.
    Loeschke K; Abb J; Farack UM; Wiebecke B
    Hepatogastroenterology; 1985 Aug; 32(4):178-80. PubMed ID: 2865200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance of HBe antigen in acute HBs antigen-positive hepatitis (author's transl)].
    Maier KP; Haas H; Urbanke R; Blum H; Kluge F; Berthold H; Lesch R; Frösner G; Deinhardt F; Gerok W
    Dtsch Med Wochenschr; 1980 Aug; 105(34):1179-83. PubMed ID: 6780291
    [No Abstract]   [Full Text] [Related]  

  • 36. Serological survey of hepatitis B virus (HBV) markers in out- and in-patients in a university hospital.
    Nakagomi O; Suzuki T; Oyamada H; Kaneda E; Saruta Y; Uesugi S
    Tohoku J Exp Med; 1984 Feb; 142(2):227-8. PubMed ID: 6372162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B surface antigen and e antigen in pleural effusion: a case report.
    Tabor E; Russell RP; Gerety RJ; Barker LF; Hillis WD; Jackson DR
    Gastroenterology; 1977 Nov; 73(5):1157-9. PubMed ID: 908498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The significance of the HBeAg/anti-HBe system in hemodialysis patients. A multicenter study.
    Fiaccadori F; David S; Faggion G; Feriani N; Ferrari C; Franco V; Giuberti T; Grutta D'Auria C; La Greca G; Magnani G
    Infection; 1984; 12(1):23-6. PubMed ID: 6368400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of hepatitis B virus infection in children born to HBsAg positive/HBeAg positive mothers. Preliminary results of active and passive-active immunization.
    Goudeau A; Lo KJ; Coursaget P; Tong MJ; Yeh CL; Tsai YT; Lee JK; Wu TC; Yeh SH; Lee SD
    Dev Biol Stand; 1983; 54():399-404. PubMed ID: 6228473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence of HBeAg, DNA polymerase activity, Dane particle in different categories of HBsAg carriers and evidence of hepatitis type B infection in their family contacts.
    Zanetti AR; Ferroni P
    Boll Ist Sieroter Milan; 1977 Mar; 56(1):79-86. PubMed ID: 861076
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.